日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

Biochemistry and regulation of histone lysine L-lactylation

组蛋白赖氨酸L-乳酰化的生物化学和调控

Sheng, Xinlei; Lin, Hening; Cole, Philip A; Zhao, Yingming

Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial

二甲双胍改善下肢周围动脉疾病患者步行能力:PERMET随机临床试验

McDermott, Mary M; Domanchuk, Kathryn J; Tian, Lu; Zhao, Lihui; Zhang, Dongxue; Bazzano, Lydia; Berceli, Scott; Criqui, Michael H; Ferrucci, Luigi; Guralnik, Jack M; Leeuwenburgh, Christiaan; Ho, Karen J; Ismaeel, Ahmed; Kibbe, Melina R; Korcarz, Claudia; Kosmac, Kate; Lloyd-Jones, Donald; Peterson, Charlotte A; Stein, James H; Sufit, Robert; Wilkins, John; Polonsky, Tamar S

Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial

围手术期以 Penpulimab 为基础的联合疗法治疗可切除非小细胞肺癌患者(ALTER-L043):一项开放标签、多中心、随机、II 期试验

Wang, Meng; Liu, Weiran; Guo, Hongbo; Long, Hao; Yu, Bentong; Zhao, Guofang; Wu, Jun; Yue, Dongsheng; Zhao, Xiaoliang; Li, Chenguang; Zhang, Lianmin; Wang, Shengguang; Zhang, Qiang; Zhang, Zhenfa; Wang, Changli

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure

PRIME-HFrEF试验:一项针对心力衰竭的随机、双盲、多剂量脐带间充质干细胞治疗方案

Han, Wei; Jiao, Yuheng; Chen, Wei; Gong, Xin; Hu, Hao; Xin, Yuanfeng; Guan, Sibin; Zhao, Jun; Zhang, Qi; Yang, Bing; Pan, Jingwei; Wang, Haiyan; Lu, Qing; Chu, Shuguang; Cai, Dihui; Zheng, Liang; Jia, Wenwen; He, Zhiying; Yang, Huangtian; Sun, Yi Eve; Liu, Zhongmin

Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis

Claudin18.2特异性IL-7/XCL1修饰的CAR-T细胞在消化道癌症中的疗效和免疫调节作用:临床前和临床分析

Zhao, Xuan; Liu, Jinyan; Zhang, Zhen; Zhou, Yali; Jin, Shuiling; Zong, Hong; Wang, Feng; Song, Min; Zhong, Yali; Li, Qinglong; Pei, Bo; Yu, Yong; Gao, Ming; Ge, Wengang; Han, Lu; Ren, Jiangtao; Zhang, Yi

Diabetes and its complications: molecular mechanisms, prevention and treatment

糖尿病及其并发症:分子机制、预防和治疗

Zhao, Lijun; Yuan, Jiamin; Yang, Qing; Ma, Jing; Yang, Fenghao; Zou, Yutong; Liu, Ke; Liu, Fang

Efficacy and safety of bofanglutide, a GLP-1 receptor agonist, in Chinese adults with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial

一项随机、双盲、安慰剂对照的2b期临床试验,旨在评估GLP-1受体激动剂波方鲁肽在中国超重或肥胖成年人中的疗效和安全性。

Ji, Linong; Gao, Leili; Tian, Junhang; Dong, Ruihua; Zhang, Zhongtao; Shu, Hongyan; Zhao, Jing; Zhao, Liyuan; He, Anshun; Xie, Tian; Li, Yue; Chen, Wei

Visinin-like protein 1 disrupts calcium homeostasis and promotes atrial fibrillation in human and rodent models

视蛋白样蛋白1破坏钙稳态,并在人类和啮齿动物模型中促进心房颤动。

Xiong, Ke; Wang, Guanghua; Li, Desheng; Shao, Beihua; Chen, Zhiwen; Zou, Qicheng; Zhang, Xinrui; Dong, Yanru; Zhao, Xuxia; Yuan, Yixin; Xu, Hongtao; Liu, Yi; Liang, Dandan; Wang, Li; Zhou, Bin; Dong, Nianguo; Xie, Duanyang; Chen, Yi-Han